Guha S, Coffey E, Lu W, Lim J, Beckel J, Laties A
Exp Eye Res. 2014; 126:68-76.
PMID: 25152362
PMC: 4143779.
DOI: 10.1016/j.exer.2014.05.013.
Can Med Assoc J. 2010; 88(10):530-2.
PMID: 20327440
PMC: 1921067.
Duenas-Gonzalez A, Garcia-Lopez P, Herrera L, Medina-Franco J, Gonzalez-Fierro A, Candelaria M
Mol Cancer. 2008; 7:82.
PMID: 18947424
PMC: 2615789.
DOI: 10.1186/1476-4598-7-82.
HOBBS H, Eadie S, Somerville F
Br J Ophthalmol. 1961; 45(4):284-97.
PMID: 18170675
PMC: 510074.
DOI: 10.1136/bjo.45.4.284.
Reed H, Campbell A
Can Med Assoc J. 1962; 86:176-8.
PMID: 14490965
PMC: 1848697.
[On visual disturbances and eye changes in quinoline therapy of primary chronic articular rheumatism].
Marx R, BRECH P, MEISNER T
Klin Wochenschr. 1960; 38:443-7.
PMID: 14421930
DOI: 10.1007/BF02341627.
OCULAR COMPLICATIONS OF CHLOROQUINE THERAPY.
TAMLER E
Calif Med. 1965; 103:30-3.
PMID: 14336789
PMC: 1516106.
OCULAR COMPLICATIONS OF CHLOROQUINE THERAPY.
LLOYD L, HILTZ J
Can Med Assoc J. 1965; 92:508-13.
PMID: 14275038
PMC: 1928171.
THE VALUE AND DANGERS OF ANTIMALARIAL THERAPY IN ARTHRITIS WITH SPECIAL RELATION TO OPHTHALMIC COMPLICATIONS.
Kersley G
Proc R Soc Med. 1964; 57:669-71.
PMID: 14195851
PMC: 1898670.
PERIPHERAL NEUROPATHY FOLLOWING CHLOROQUINE THERAPY.
LOFTUS L
Can Med Assoc J. 1963; 89:917-20.
PMID: 14052974
PMC: 1921850.
Current concepts in dermatology. I.
Jackson R
Can Med Assoc J. 1963; 89:344-9.
PMID: 13964259
PMC: 1921796.
Ocular complications induced by chloroquine therapy.
Golden S, VAN DONGE N
Calif Med. 1963; 98:338-9.
PMID: 13948709
PMC: 1575738.
Antimalarial compounds in rheumatoid disease.
BAGNALL A
Can Med Assoc J. 1960; 82:1167-9.
PMID: 13795753
PMC: 1938458.
[Changes in the human electro-retinogram during long-term resochin therapy].
Schmidt B, MUELLER-LIMMROTH W, HEINMUELLER G, BOEKE W, BAEUMER A
Klin Wochenschr. 1961; 39:132-7.
PMID: 13747958
DOI: 10.1007/BF01485360.
Chloroquine diphosphate in rheumatoid arthritis. A controlled trial.
POPERT A, MEIJERS K, Sharp J, BIER F
Ann Rheum Dis. 1961; 20:18-35.
PMID: 13737086
PMC: 1007179.
DOI: 10.1136/ard.20.1.18.
Antimalarials in treatment of Sjogren's syndrome.
Heaton J
Br Med J. 1959; 1(5136):1512-3.
PMID: 13651781
PMC: 1993725.
DOI: 10.1136/bmj.1.5136.1512.
Disturbances of pigmentation with chloroquine.
Dall J, Keane J
Br Med J. 1959; 1(5134):1387-9.
PMID: 13651742
PMC: 1993594.
DOI: 10.1136/bmj.1.5134.1387.
Combination therapy for autoimmune diseases: the rheumatoid arthritis model.
Fathy N, Furst D
Springer Semin Immunopathol. 2001; 23(1-2):5-26.
PMID: 11455861
DOI: 10.1007/s002810100063.
Ocular changes resulting from therapy with amiodarone.
Ingram D, Jaggarao N, Chamberlain D
Br J Ophthalmol. 1982; 66(10):676-9.
PMID: 7115651
PMC: 1039895.
DOI: 10.1136/bjo.66.10.676.
The eye and visual nervous system: anatomy, physiology and toxicology.
MCCAA C
Environ Health Perspect. 1982; 44:1-8.
PMID: 7084144
PMC: 1568971.
DOI: 10.1289/ehp.82441.
